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Soluble guanylyl cyclaseWe characterized the nitric oxide (NO)-cyclic GMP-phosphodiesterase-5 (PDE5) pathway in Crotalus dur-
issus terriﬁcus aorta. Concentration responses curves to acetylcholine (ACh), sodium nitroprusside (SNP),
BAY41-2272 (soluble guanylyl cyclase [sGC] stimulator), BAY60-2770 (sGC activator) and tadalaﬁl (PDE5
inhibitor) were constructed in phenylephrine (10 μM)-precontracted tissues with intact (E+) or denuded
(E-) endothelium. ACh (0.0001–10 μM) and SNP (0.0001–10 μM) relaxed aorta, which were reduced by
the NO synthase (L-NAME,100 μM) or the sGC inhibitors (ODQ, 10 μM). Tadalaﬁl (0.0001–10 μM) relaxed
E+ rings with potency (pEC50) and maximal response (Emax) values of 7.34±0.02 and 105±8%, respec-
tively. E- or ODQ treatment signiﬁcantly (Pb0.05) reduced tadalaﬁl relaxations (66±18% and 71±7%, re-
spectively). BAY41-2272 (0.0001–300 nM) produced concentration-dependent relaxations in E+ rings,
which were reduced by addition of either ODQ or L-NAME (16.0- and 5.2-fold rightward shifts, respective-
ly). The relaxation of BAY60-2770 was markedly potentiated by ODQ and L-NAME (41.0- and 9.7-fold left-
ward shifts, respectively), whereas in E- the pEC50 values were shifted by 7-fold to the right.
Immunohistochemistry, followed validation by transcriptomic analysis, revealed the presence of eNOS in
endothelium, whereas nNOS was observed only in perivascular nerves. sGC and PDE5 were expressed in
smooth muscle. Thus, NO–sGC–PDE5 pathway is evolutionarily present in Crotalus sp. vessels, and has a
remarkable degree of functional similarity to mammalian vessels.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
In mammals, nitric oxide (NO) is an important signaling mole-
cule that is generated by NO synthase (NOS). Soluble guanylyl cy-
clase (sGC) is the physiological receptor of NO (Arnold et al.,
1977; Poulos, 2006). In the presence of NO, sGC is activated to con-
vert guanosine triphosphate (GTP) to cyclic guanosine 3′, 5′ mono-
phosphate (cGMP), which in turn has a direct inﬂuence on various
biological processes, including those of the cardiovascular and neu-
ral systems. The biological effects of cGMP are mediated by three
major types of intracellular effectors, namely: cGMP-dependent
protein kinases I and II, cGMP-gated ion channels and cGMP-
regulated phosphodiesterases (PDEs) (Beavo, 1995). Mammalian
PDEs are categorized into 11 families based on sequence homology,
enzymatic properties and sensitivity to inhibitors. PDE5A plays aology, Faculty of Medical Sci-
1 Campinas (SP), Brazil. Tel.:
ónica).
evier OA license.prominent role in cGMP breakdown including visual response,
smooth muscle relaxation, platelet aggregation, ﬂuid homeostasis,
immune response and cardiac contractility (Francis et al., 2001).
Few studies have investigated the role of PDEs in the cardiovascular
system from non-mammalian vertebrates (Gauthier and Soustre,
1992; Wasser et al., 1997).
Studies in birds (Hasegawa and Nishimura, 1991), reptiles
(Broughton and Donald, 2007) and amphibians (Rumbaut et al.,
1995; Knight and Burnstock, 1996) have provided evidence that an
endothelial NO system is present in the vasculature, although this ev-
idence is controversial. For instance, in eel aorta, immunoreactivity
for nNOS is found in the outer layers of the vessel wall, and no
eNOS staining is observed in endothelial cells (Jennings et al., 2004).
In aorta from the toad Bufo marinus, relaxations to acetylcholine
(ACh) occurs even when the endothelium was removed and neither
NADPH-diaphorase positive nor NOS-immunoreactive cells in endo-
thelium was observed (Broughton and Donald, 2002). However, in
isolated aorta from leopard frog, ACh-induced relaxations are inhib-
ited by the NOS inhibitor Nω-nitro-L-arginine methyl ester (L-
NAME) (Knight and Burnstock, 1996).
434 F.Z. Mónica et al. / Comparative Biochemistry and Physiology, Part C 155 (2012) 433–439The role of NO pathway in the control of vascular tone in reptile
has received less attention than mammals. The majority of the studies
have focused on in vivo and in vitro assays. For instance, the NO-donor
sodium nitroprusside (SNP) led to a large systemic vasodilatation in
reptiles, including rattlesnake, turtles and lizards, indicating a poten-
tial role for NO in regulating reptile vascular tone (Galli et al., 2005).
Acetylcholine induces concentration-dependent relaxations in isolat-
ed aorta from estuarine crocodile Crocodylus porosus that is sensitive
to NOS and sGC inhibitors (Broughton and Donald, 2007). To date,
no studies have explored the presence and functionality of sGC and
PDE5 in reptile vessels. Therefore, we have characterized by function-
al assays in vitro, immunohistochemistry and transcriptomic analysis
the complete NO-cGMP-PDE5 pathway in the aorta from the rattle-
snake Crotalus durissus terriﬁcus.
2. Material and methods
2.1. Experimental animals
All experimental procedures using rattlesnakes were approved
by an institutional Animal Care and Use Committee (CEUA/UNI-
CAMP: 1655-1) and were done in accordance with the Ethical Prin-
ciples for Animal Research adopted by the Brazilian College for
Animal Experimentation (COBEA). The use of these animals was au-
thorized by the Brazilian Institute of Environment (IBAMA) (Sisbio:
18020-1). Male Crotalus durissus terriﬁcus (body mass weight:
400–750 g) were provided by the serpentarium of the Center for
the Study of Nature at the University of Vale do Paraiba (UNIVAP,
São José dos Campos, SP, Brazil).
2.2. Functional studies
The animals were ﬁrst anesthetized with isoﬂurane followed by
ketamine (100 mg/kg, i.p) and xilazine (10 mg/kg, i.p.). The aorta
was dissected out and cut into eight rings of approximately 3 mm in
length after removal of surrounding fat and connective tissues. In
some ring preparations, the endotheliumwas removed by gently rub-
bing of the intimal surface with a ﬁne-tipped forceps. Each ring was
suspended between two wire hooks and mounted under 10 mN pas-
sive tension in 10-ml organ chambers ﬁlled with Krebs’ solution of
the following composition (mM): 118 NaCl, 25 NaHCO3, 5.6 glucose,
4.7 KCl, 1.2 KH2PO4, 1.17 MgSO4, 2.5 CaCl2 at 27 °C, pH 7.4 and aerated
continuously with 95% O2 and 5% CO2 (Knight and Burnstock, 1995,
1996, Yoshinaga et al., 2007; Mesquita et al., 2008). To record the de-
velopment of isometric tension, hooks were ﬁxed to the bottom of the
chamber and to a force transducer (AdInstruments, MA, USA) con-
nected to a PowerLab 4/30 data-acquisition system (Software Chart,
version 7.0; ADInstruments, Colorado Springs, MA, USA). All rings
were allowed to equilibrate for 45 min. Bathing solution was replaced
every 15 min, and baseline tension adjusted when necessary. The ab-
sence of endothelium was veriﬁed by the lack of responsiveness to
acetylcholine (ACh, 3 μM) in vessels precontracted with phenyleph-
rine (PE, 10 μM). Tissues that did not relax to ACh were considered
as endothelium denuded. Rings were then washed several times to
restore tension to baseline.
2.3. Concentration-response curves
In the ﬁrst set of experiments, concentration response curves to
ACh (0.0001–10 μM) or SNP (0.0001–10 μM) were constructed in
endothelium-intact (E+) or -denuded (E-) preparations in the ab-
sence and in the presence of Nω-nitro-L-arginine methyl ester (L-
NAME, 100 μM) or the sGC inhibitor 1H-[1,2,4] oxadiazolo [4,3,-a]qui-
noxalin-1-one (ODQ, 10 μM). The second set of experiments con-
sisted of assessing whether the presence of endothelium interferes
with the aorta relaxations induced by tadalaﬁl (PDE5 inhibitor;0.0001–10 μM), BAY 41–2272 (sGC stimulator, 0.0001–30 μM) or
BAY 60–2770 (sGC activator, 0.001–3000 nM). Hence, concentration
responses curves to tadalaﬁl, BAY 41–2272 or BAY 60–2770 were
constructed in E+ and E-, as well as in the presence of either ODQ
(10 μM) or L-NAME (100 μM) (Teixeira et al., 2006).
Nonlinear regression analysis to determine the pEC50 was done
using GraphPad Prism (GraphPad Software, San Diego, CA) with the
constraint that=0. All concentration-response data were evaluated
for a ﬁt to a logistics function in the form: E=Emax/([1+(10c/
10x)n] + ; where E is the effect above basal; Emax is the maximum re-
sponse produced by ACh, SNP, BAY 41–2272, BAY 60–2770 or tadala-
ﬁl; c is the logarithm of the EC50, the concentration of drug that
produces a halfmaximal response; x is the logarithm of the concentra-
tion of the drug; the exponential term, n, is a curve-ﬁtting parameter
that deﬁnes the slope of the concentration-response line; and is the
response observed in the absence of added drug.
2.4. Immunohistochemistry
Aortas from three specimens (n=3) were ﬁxed by immersion in
phosphate-buffered formalin (10%) for 24 h. After macroscopic exam-
ination, aortas were cut in rings, all of which were dehydrated,
cleared in xylene, and embedded in parafﬁn. Transversal sections
(4 μm) were cut and stained for eNOS, nNOS, sGC and PDE5 by an
immunoperoxidase method. Brieﬂy, three levels of 4-μm thick sec-
tions were obtained from each parafﬁn block, placed on silanized
slides, deparafﬁnized in xylene and rehydrated. Endogenous peroxi-
dase activity was quenched by incubating the slides with 3% H2O2
for 10 min. Antigen retrieval was performed by heating slides in cit-
rate buffer (10 mM, pH 6.0) at 95 °C for 30 min. As primary polyclonal
antibodies, we used anti-eNOS (polyclonal, Abcam, diluted at 1:50),
anti-nNOS (polyclonal, Abcam, diluted 1:200), anti-sGC (polyclonal,
Abcam, diluted at 1:50) and anti-PDE5 (polyclonal rabbit, Abcam, di-
luted at 1:10). Antigen-antibody binding was detected using the Ad-
vance system (Dako). Staining was achieved using 3,3-
diamonobenzidine tetrahydrochlride (Sigma-Aldrich, St. Louis, MO,
USA) and counterstaining using Mayer's haematoxilin. All reactions
were performed using appropriate positive (mouse aorta tissue)
and negative (omission of the primary antibody) controls. Microscop-
ic examination and photomicrographic documentation of immuno-
stained sections were performed using a bright ﬁeld microscope
(Leica DM5000 B) connected to a digital camera (Leica DFC360 FX,
Leica, Germany). (Capel et al., 2011)
2.5. Transcriptome proﬁle of the Crotalus durissus aorta
Isolation and puriﬁcation of aorta and brain RNA transcripts were
performed with Trizol (Invitrogen). Brieﬂy, the tissues were homoge-
nized with Trizol, followed by addition of 20% chloroform and centri-
fugation. The isolated RNA was pelleted with isopropyl alcohol and
washed with 75% ethanol. The cDNA was sequenced with Roche 454
GS FLX Titanium equipment at Helixxa Bases for Life (Campinas, São
Paulo, Brazil). Aorta and brain library comprised 310,381 and
364,708 reads with an average size of reads size of 290 and 293 bp,
respectively. Assemblies were executed using a combination of New-
bler Assembler and iAssembler. Aorta and brain library reads were
grouped, respectively, into 59,790 and 87,841 unigenes, including
singlet sequences. We searched genes for NOS, sGC and PDE5 in
snake aorta unigenes, whereas in the brain library just NOS was
searched. All protein sequences used in comparisons against snake
unigenes were taken from UniProt. The comparisons were performed
using BLAST (tblastn), and unigenes with e-values better than e-10
against. We then used blastx to compare each candidate to the NR
protein database of GenBank (database containing virtually all public-
ly known proteins from all species). If the best NR hit of an eNOS can-
didate was with a eNOS of any species, we consider the candidate
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iNOS, sGC, and PDE5). Bioinformatic analysis was carried out by Scylla
Informatics (Campinas, Sao Paulo, Brazil).
2.6. Drugs and antibodies
Antibodies directed against eNOS, nNOS, sGC and PDE5 were pur-
chased from Abcam (Cambridge, MA). Acetylcholine, L-NAME, 1H-
[1,2,4] oxadiazolo [4,3,-a]quinoxalin-1-one (ODQ) and phenylephrine
were purchased from Sigma Chemical (St Louis, MO, USA). The com-
pounds BAY 41–2272 and BAY 60–2770 were provided by Pharma
Research Center, Bayer AG (Wuppertal, Germany), and tadalaﬁl by
BioLab Farmaceutica (Sao Paulo, SP, Brazil). Stock solutions of ACh,
L-NAME and phenylephrine were prepared in deionized water and
stored in aliquots at −20 °C. BAY 41–2272, BAY 60–2770, ODQ and
tadalaﬁl were initially prepared as stock solutions in dimethylsulph-
oxide (DMSO) and kept at −20 °C. The ﬁnal concentration of DMSO
did not exceed 0.3%. Preliminary experiments ascertained the lack
of response of aortic tissue to DMSO at the concentrations used.
2.7. Statistical analysis
Experimental values were calculated relative to the maximal
changes from the contraction produced by phenylephrine in each
tissue, which was taken as 100%. The pEC50 values for ACh, SNP,
BAY 41–2272, BAY 60–2770 and tadalaﬁl were determined as -log
of the molar concentration to produce 50% of the maximal relaxa-
tion in phenylephrine-contracted tissues. Data are shown as the
percentage of relaxation of n experiments, expressed as the
mean±SEM. One-way analysis of variances (ANOVA) followed by
a Bonferroni test were performed. Pb0.05 was accepted asFig. 1. Concentration-response curves to acetylcholine (A, ACh, 0.0001–10 μM) and sodium
(CTL) and in the presence of L-NAME (100 μM) or ODQ (10 μM). Experimental values were
ephrine (10 μM), which was taken as 100%. Data represent the means±S.E.M. of n=4–6 ex
denuded- (D) endothelium.signiﬁcant. A program package was used for the statistical analysis
of all data (GraphPAD Instat, 1997, version 3.0; GraphPad Prism
Software, San Diego, CA, USA).
3. Results
3.1. Vasorelaxation evoked by ACh and SNP
Phenylephrine (10 μM) caused sub-maximal contraction in aorta
and generated an active force leading to a delta of contraction of
9.0±2.3 mN in rings with intact endothelium (n=4). Addition
of acetylcholine (ACh, 0.0001–10 μM) in endothelium-intact
preparations caused concentration-dependent relaxations in
phenylephrine-precontracted aortic rings, with a potency (pEC50)
and maximal responses values (Emax) of 6.55±0.10 and 74±9%, re-
spectively (n=6) (Fig. 1A and C). Acetylcholine (3 μM) failed to
relax endothelium-denuded aortic rings (Fig. 1 A and D). In
endothelium-intact preparations, prior addition of L-NAME
(100 μM) markedly reduced the relaxations induced by ACh (Fig. 1A).
Cumulative addition of the NO donor SNP (0.0001–10 μM) pro-
duced concentration-dependent relaxations with a pEC50 and Emax
values of 7.52±0.09 and 103±5%, respectively (n=5). Prior addi-
tion of the sGC inhibitor ODQ (10 μM) nearly abolished SNP-
induced aortic relaxations (Fig. 1B).
3.2. Vasorelaxation evoked by the PDE5 inhibitor tadalaﬁl
The selective PDE5 inhibitor tadalaﬁl (0.0001–10 μM) evoked re-
laxations of endothelium-intact rings in a concentration-dependent
manner (pEC50=7.34±0.02; n=3). Fig. 2 shows that addition of
ODQ (10 μM) reduced the relaxation responses to tadalaﬁl whennitroprusside (B, SNP; 0.0001–10 μM) in Crotalus durissus terriﬁcus aorta in the absence
calculated relative to the maximal changes from the contraction produced by phenyl-
periments. Representative tracings of the relaxation induced by ACh in intact- (C) and
Fig. 2. Concentration-responses curves to the phosphodiesterase-5 (PDE5) inhibitor,
tadalaﬁl (0.0001–10 μM) in endothelium intact (E+) in aorta (A) pre-contracted
with phenylephrine (10 μM) in the absence (E+) and in the presence of ODQ
(10 μM). Maximal responses (Emax) values for tadalaﬁl in endothelium-intact (E+) or
-denuded (E−) preparations are showed in B. Experimental values were calculated rel-
ative to the maximal changes from the contraction produced by phenylephrine, which
was taken as 100%. Data are presented as the means±S.E.M., n=3. *Pb0.05 in com-
parison with E+rings.
Fig. 3. Concentration-response curves to the soluble guanylyl cyclase (sGC) stimulator
BAY 41–2272 (A, 0.0001–30 μM) or activator BAY 60–2770 (0.001–3000 nM) in
endothelium-intact (E+) and -denuded (E−) in Crotalus durissus terriﬁcus aorta in the
absence (E+) and in the presence of either ODQ (10 μM) or L-NAME (100 μM). Exper-
imental values were calculated relative to the maximal changes from the contraction
induced by phenylephrine (10 μM), which was taken as 100%. Data represent the
means±SEM of n=3–4 experiments.
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tively). In endothelium-denuded aorta, tadalaﬁl-induced relaxations
were partly (but signiﬁcantly) attenuated, by about of 37% (Pb0.05;
Fig. 2B).
3.3. Relaxing responses to haem-dependent and -independent GC stimu-
lator and activator (BAY 41–2272 and BAY 60–2770)]
In endothelium-intact aorta rings, addition of the heme-
dependent sGC stimulator BAY 41–2272 (0.0001–30 μM)
concentration-dependently relaxed the aortic rings with a pEC50
and Emax of 7.11±0.03 and 106±4.2%, respectively (Fig. 3A). Addi-
tion of either ODQ (10 μM; n=3) or L-NAME (100 μM, n=3) caused
16.0 and 5.2-fold rightward shifts (Pb0.001), respectively, in the
concentration-response curves to BAY 41–2272 without affecting
the maximal responses (89±12 and 99±4%, respectively). In
endothelium-denuded aortic rings, the potency value for BAY
41–2272 was markedly reduced (6.22±0.17, Pb0.001, N=4) in
comparison with intact rings without affecting the maximal response
(104±1.7%, Fig. 3A). The addition of tadalaﬁl (100 nM, n=3) caused
2.1 fold leftward shifts (Pb0.01) in the relaxation to BAY 41–2272
without affecting the Emax (114±2.2 and 108±3%, respectively).
The heme-independent sGC activator BAY 60–2770 (0.001–
3000 nM) produced concentration-dependent relaxations in endo-
thelium intact aorta with the pEC50 and Emax values of 9.17±0.06
and 104±1.6% (n=4), respectively. Incubation with ODQ (10 μM;
n=4) or L-NAME (100 μM, n=4) produced leftward shifts in the
BAY 60-2770-induced relaxations (41.0- and 9.7-fold, respectively,Pb0.001; Fig. 3B). Unexpectedly, the pEC50 for BAY 60–2770 in endo-
thelium denuded rings was markedly reduced (8.32±0.08, Pb0.001,
n=4) without affecting the Emax (104±1.6%).3.4. Immunohistochemistry
Immunoreactivities (IR) indicated the presence of eNOS in aortic
endothelia, whereas nNOS IR was observed in perivascular nerves lo-
calized only in the adventitial layer (Fig. 4A). Soluble guanylyl cyclase
and PDE5 IR were mainly expressed in aortic smooth musculature
(Fig. 4A). Fig. 4B 1–4 shows the staining for eNOS, nNOS, sGC and
PDE5 in mouse aorta, respectively (used as positive controls). No im-
munoreactivity was observed when the primary antibody was omit-
ted (Fig. 4B).3.5. Transcriptome proﬁle for NOS, sGC and PDE5 in Crotalus durissus
aorta and brain library
The antigen sequence of eNOS and nNOS antibodies used for im-
munohistochemistry assays was compared to that of snake aorta
and brain library. With regard to nNOS antibody (seven aminoacids
to the left and right of position 1417 of human nNOS), a high similar-
ity (93% identity) was found in the two libraries, whereas for eNOS
antibody (amino-acids 1179–1194 of human eNOS) an identity of
60% was observed in aorta library. With respect to iNOS, although
several unigenes showed signiﬁcant alignments, it was not possible
to clearly associate any of them with this enzyme, since they exhib-
ited alignments of comparable quality to nNOS or eNOS.
Fig. 4. Immunoreactivity (IR, arrows) in Crotalus durissus terriﬁcus aorta (panel A) indicates the presence of eNOS (original magniﬁcation 400 times) in aorta endothelia, whereas
nNOS (original magniﬁcation 400 times) was observed only in perivascular nerves. Soluble guanylyl cyclase (sGC) and phosphodiesterase type 5 (PDE5) IR were mainly expressed
in aortic smooth musculature. Panels B 1–4 show staining for eNOS, nNOS, sGC and PDE5 in mouse aorta, respectively (used as a positive control). No immunoreactivity was ob-
served when the primary antibody was omitted (Fig. 4 b5). Scale bars: in ﬁgure “nNOS” from subset “a”, scale bar equals 10 μm; in the other ﬁgures, scale bars represent 100 μm.
437F.Z. Mónica et al. / Comparative Biochemistry and Physiology, Part C 155 (2012) 433–439Soluble guanylyl cyclase subunits alpha-2 and beta-1 and PDE5 of
snake aorta showed a high similarity (88, 98 and 80% identity, respec-
tively) when compared to human library (Table 1).
4. Discussion
The present study is the ﬁrst to explore functionally the complete
NO-cGMP-PDE5 pathway in Crotalus vessels. Our ﬁndings that ACh,
BAY 41–2272, BAY 60–2770 and tadalaﬁl potently relax isolated
aorta from Crotalus durissus terriﬁcus indicate that this signaling path-
way is highly conserved among species.
Accumulated evidence shows that NO is an important mediator in
the entire phylogenetic scale, including invertebrates and non-
mammals vertebrates (Toda and Ayajiki, 2006). Nitric oxide release
by ACh from endothelium via activation of muscarinic M3 receptors
(Jaiswal et al., 1991) is one of the most acceptable tools to verify the
endothelium integrity. In isolated aortic arches of frog, ACh-induced
relaxations are abolished by the NOS inhibitor L-NAME and by endo-
thelium denudation (Knight and Burnstock, 1996). Adenosine-
induced NO release from endothelium in trout coronary vasculature
is also reduced by the NOS inhibitor L-NA and by chemical denuda-
tion of the endothelial layer (Mustafa and Agnisola, 1998). However,
the source of NO, whether from eNOS or nNOS, is still unclear in the
lower vertebrates (Jennings et al., 2004; Capel et al., 2011). In our
study, ACh concentration-dependently relaxed Crotalus isolated
aorta, which was abolished by endothelium removal. Moreover,Table 1
Coverage, alignments and identity in snake aorta library.
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Unigenes were compared to human sGC and PDE5 enzymes.eNOS-positive staining was observed only at the level of the endothe-
lium, whereas nNOS was expressed in the perivascular nerves on the
adventitia layer. The transcriptomic analysis showed a high similarity
(>90%) between the antigen sequence of nNOS antibody and that of
snake aorta library. Since immunoreactive for eNOS (but not for
nNOS) was observed on the endothelial cells, it is possible to predict
that the main source of NO in rattlesnake aorta comes from the
eNOS isoform.
To date, the presence of sGC in birds and reptiles has been ob-
served indirectly using NO donors such as SNP, which causes vascular
smooth muscle relaxations (Skovgaard et al., 2005; Broughton and
Donald, 2007). The sGC is typically found as a heterodimer, consisting
of a larger α-subunit and a smaller haem-binding β-subunit. Four
human sGC subunits exist, namely: α1, α2, β1 and β2 of which the
α1/β1 and α2/β1 heterodimers are the best characterized
(Russwurm et al., 1998; Zabel et al., 1998). Soluble guanylyl cyclase
also contains a prosthetic heme moiety that confers sensitivity to ac-
tivation by NO (Iyer et al., 2003; Pellicena et al., 2004). In the present
study, both α2 and β1 sGC subunits of Crotalus aorta showed high
similarity with the human sGC subunits library. These ﬁndings are
consistent with our functional assays showing that BAY 41–2272 pro-
duces ODQ-sensitive vasorelaxations in aorta. Moreover, as seen in
mammalian tissues (Teixeira et al., 2006), prior incubation with the
NOS inhibitor L-NAME signiﬁcantly reduced the potency of BAY
41–2272 in aorta, indicating that endogenous NO contributes to BAY
41–2272 relaxing responses.
The NO-independent class of drugs, sGC stimulators and activa-
tors, have been used to distinguish between reduced heme-
containing and heme-free sGC. BAY 41–2272 directly stimulates
sGC in the absence of NO but requires the presence of the prosthet-
ic heme group (Stasch et al., 2001). On the other hand, BAY
60–2770 increases the catalytic activity of the enzyme in a NO-
and heme-independent manner (Stasch et al., 2002). The com-
pound ODQ inhibits NO-stimulated sGC activity and has been ex-
tensively used to study the function of the NO–cGMP transduction
pathway. The inhibitory effect of ODQ on NO-stimulated sGC is
due to changes in the oxidation state of the heme moiety, without
adversely affecting the catalytic activity of the enzyme (Garthwaite
et al., 1995; Zhao et al., 2000).
438 F.Z. Mónica et al. / Comparative Biochemistry and Physiology, Part C 155 (2012) 433–439In the present study, BAY 60–2770 was 114 times more potent
than BAY 41–2272 in relaxing the aortic rings. Incubation with ODQ
markedly reduced BAY 41-2272-induced aorta relaxations, as previ-
ously reported for different mammalian vessels, including rabbit
aorta (Priviero et al., 2005). Most interestingly, however, BAY 60-
2770-induced relaxing responses were strongly potentiated after ad-
dition of ODQ, suggesting that even in snake sGC exists in both re-
duced and oxidized/haem free states. This is consistent with a
previous study showing that BAY 60–2770 stimulates rat sGC by 53-
fold, which is further increased to 176-fold in the presence of ODQ
(Knorr et al., 2008). Moreover, in anaesthetized rats, the pulmonary
vasodilator responses to BAY 60–2770 were shown to be enhanced
by ODQ (Pankey et al., 2011).
The role of endogenous NO in mediating vasodilator responses to
BAY 60–2770 was also investigated. Our results showed that NOS in-
hibition by L-NAME increased the potency value of BAY 60–2770. This
ﬁnding corroborates with a study in anaesthetized rats, where the de-
crease in pulmonary arterial pressure in response to intravenous ad-
ministration of BAY 60–2770 was potentiated by prior L-NAME
administration (Pankey et al., 2011). This suggested to authors that
the vasodilator responses to BAY 60–2770 are not dependent on the
presence of endogenous NO. One may speculate that the absence of
NO would favor the binding and activation of sGC by BAY 60–2770.
However, an intriguing observation was that the absence of endothe-
lium in Crotalus aorta rather reduced the potency of BAY 60–2770. It
remains to be established whether similar paradox also occurs in
mammalian vessel. Heme-free sGC seem to be a physiological phe-
nomenon, suggesting that there may also be a physiological activator
compound and thus an entire NO-independent signaling function for
heme-free sGC.
Phosphodiesterase type 5 enzyme converts the intracellular sec-
ond messenger cGMP to the nucleotide GMP. PDE5 inhibitors com-
pete with the substrate cGMP for binding to the protein at the
catalytic site (Corbin et al., 2000). Sildenaﬁl ampliﬁes vasorelaxation
induced by NO donors in human vessels (Cremers et al., 2003) and
cause dilation of epicardial coronary arteries when administered to
patients in coronary diseases. This is the ﬁrst study to show that
PDE5 is not only highly conserved (80% identity by transcriptome
analysis), but functionally active in Crotalus vascular smooth muscle.
The relaxations evoked by tadalaﬁl in Crotalus aorta clearly involve
the NO/cGMP pathway because it was markedly reduced after endo-
thelium removal or by adding ODQ. This is further supported by the
ﬁnding that tadalaﬁl potently increased the relaxing response of
BAY 41–2272 in aorta from Crotalus. These ﬁndings are in accordance
with previous reports where vascular relaxation mediated by PDE5
inhibitors (e.g, sildenaﬁl, zaprinast) also involves the NO/cGMP sig-
naling pathway in rat aorta (Mochida et al., 2002), and guinea pig
basilar artery (Kruuse et al., 2001).The immunohistochemistry for
sGC and PDE5 in snake vessel has been conﬁrmed by Western blot
analysis (Capel et al., 2011).5. Conclusions
Our results demonstrate that the NO-cGMP-PDE5 pathway is pre-
sent in Crotalus vessels and has a remarkable degree of functional and
genomic similarity to mammalian vessels. It is possible that the evo-
lutionary differences observed in the cardiovascular system reactivity
may be related to different sensitivity to and/or presence of new me-
diators, rather than changes in the transduction mechanisms.References
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